A general and efficient method for the synthesis of pronucleotide (ProTide) 5′-phosphoramidate monoesters is reported. This method consists of a highly stereoselective 5′-phosphorylation mediated by dimethylaluminum chloride to afford the desired target ProTides in excellent yields without employing 3′-protection strategies. The application of this methodology to the synthesis of a number of pharmaceutically relevant compounds currently marketed or under investigation in clinical research is demonstrated
A facile and novel synthetic route to MC-1220 was achieved by condensation of 4,6-dichloro-N,N-5-tri...
We report the application of our phosphoramidate ProTide technology to various 4′-substituted ribonu...
The masking of nucleoside phosphate and phosphonate groups by an aryl motif and an amino acid ester,...
A general and efficient method for the synthesis of pronucleotide (ProTide) 5'-phosphoramidate monoe...
We herein report the application of the phosphorodiamidate phosphate prodrug approach to a series of...
The ProTide technology is a prodrug approach developed for the efficient intracellular delivery of ...
The first copper-catalysed diastereoselective synthesis of P-chiral phosphoramidate prodrugs (ProTid...
A new method for the construction of aryloxy)phosphoramidate nucleoside prodrugs is presented. An(ar...
The preparation of Sofosbuvir, the potent key component of recent Hepatitis C (HCV) infection therap...
The first diastereoselective synthesis of aryloxy phosphoramidate prodrugs of 3'-deoxy-2',3'-didehyd...
The use of pronucleotides to circumvent the well-known drawbacks of nucleotide analogs has played a ...
A new and facile synthetic pathway to metabolically stable 5′-methylene-bis(pivaloyloxymethyl)(POM)p...
The first diastereoselective synthesis of aryloxyphosphoramidate prodrugs of 3′-deoxy-2′,3′-didehydr...
Prodrug technologies aimed at delivering nucleoside monophosphates into cells (protides) have proved...
A facile and novel synthetic route to MC-1220 was achieved by condensation of 4,6-dichloro-N,N-5-tri...
We report the application of our phosphoramidate ProTide technology to various 4′-substituted ribonu...
The masking of nucleoside phosphate and phosphonate groups by an aryl motif and an amino acid ester,...
A general and efficient method for the synthesis of pronucleotide (ProTide) 5'-phosphoramidate monoe...
We herein report the application of the phosphorodiamidate phosphate prodrug approach to a series of...
The ProTide technology is a prodrug approach developed for the efficient intracellular delivery of ...
The first copper-catalysed diastereoselective synthesis of P-chiral phosphoramidate prodrugs (ProTid...
A new method for the construction of aryloxy)phosphoramidate nucleoside prodrugs is presented. An(ar...
The preparation of Sofosbuvir, the potent key component of recent Hepatitis C (HCV) infection therap...
The first diastereoselective synthesis of aryloxy phosphoramidate prodrugs of 3'-deoxy-2',3'-didehyd...
The use of pronucleotides to circumvent the well-known drawbacks of nucleotide analogs has played a ...
A new and facile synthetic pathway to metabolically stable 5′-methylene-bis(pivaloyloxymethyl)(POM)p...
The first diastereoselective synthesis of aryloxyphosphoramidate prodrugs of 3′-deoxy-2′,3′-didehydr...
Prodrug technologies aimed at delivering nucleoside monophosphates into cells (protides) have proved...
A facile and novel synthetic route to MC-1220 was achieved by condensation of 4,6-dichloro-N,N-5-tri...
We report the application of our phosphoramidate ProTide technology to various 4′-substituted ribonu...
The masking of nucleoside phosphate and phosphonate groups by an aryl motif and an amino acid ester,...